T1	MajorClaim 0 110	Low serum vitamin D has been associated with metabolic syndrome and Non-alcoholic fatty liver disease (NAFLD).
T2	Claim 1154 1291	significant reduction of serum alkaline phosphatase and GGT were seen with vitamin D and calcitriol supplementation from baseline levels,
T3	Claim 1292 1399	no beneficial effects was seen when comparing vitamin D, calcitriol and placebo groups at the end of trial.
T4	Premise 954 1147	There was no statistically significant difference between placebo, calcitriol, vitamin D groups in terms of serum aminotransferase, alkaline phosphatase, serum GGT and lipid profile (P > 0.05).
T5	Premise 796 953	Serum and gamma glutamyl transferase (GGT) level was also significantly decreased compared to the baseline levels after 12 weeks of treatment with vitamin D.
T6	Premise 629 795	After 12 weeks of treatment, serum alkaline phosphatase levels was significantly decreased from baseline levels in vitamin D and calcitriol treated groups (P < 0.05).
R1	Support Arg1:T4 Arg2:T3	
R2	Support Arg1:T6 Arg2:T2	
